TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer
Condition: HER2-Positive Breast Cancer Intervention: Drug: TCHP Sponsor: Guangdong General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Hospitals | Neoadjuvant Therapy | Research